Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Latest filing published 14 May 2025 for Idexx Laboratories INC /de, €309k. Read the official filing
Filing timeline
BuySaleDaniel M. Junius
Insider track record
Disclosed buys
2
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Daniel M. Junius: trading record in brief
Daniel M. Junius is a declared insider at 3 companies (board member); the most frequent names are Idexx Laboratories INC /de, Crescent Biopharma, Inc. and ImmunoGen, Inc. We count 25 filings; the first trade dates from 4 January 2016 and the latest from 13 May 2025.
On the open market, the record shows 2 purchases worth €79k and 1 sale. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 15 share grants and 7 option exercises.
On 14 May 2025 came the latest disclosure, an option exercise for €309k in Idexx Laboratories INC /de. The clock since the last published purchase (11 May 2023) now reads 1,256 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Daniel M. Junius
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
1,404 shares@ US$245.7915.5% of flowCommon StockSEC:0000874716-25-000090:0
262 shares0Common StockSEC:0000874716-25-000079:0
5,209 shares@ US$3.0015.6% of flowCommon StockSEC:0001415889-24-009745:0
14 shares@ US$521.030.3% of flowCommon StockSEC:0000874716-24-000009:0
19 shares@ US$396.390.4% of flowCommon StockSEC:0000874716-23-000129:0
14 shares@ US$552.780.4% of flowCommon StockSEC:0000874716-23-000101:0
30,000 shares@ US$1.5645.8% of flowCommon StockSEC:0001209191-23-028816:0
Canonical exit: 8 Aug 2023 (T+90)
13 shares@ US$492.160.3% of flowCommon StockSEC:0000874716-23-000035:0
2,187 shares@ US$206.6221.3% of flowCommon StockSEC:0001567619-23-003312:0
14 shares@ US$482.950.3% of flowCommon StockSEC:0001567619-23-001663:0
3,046 shares@ US$160.2823.3% of flowCommon StockSEC:0001567619-22-021390:0
20,000 shares@ US$1.8738.7% of flowCommon StockSEC:0001209191-22-057823:0
Canonical exit: 15 Feb 2023 (T+90)
18 shares@ US$364.280.3% of flowCommon StockSEC:0001567619-22-019020:0
16 shares@ US$399.180.3% of flowCommon StockSEC:0001567619-22-014808:0
15 shares@ US$430.480.0000% mcap0.8% of flowCommon StockSEC:0001567619-22-009426:0
13 shares@ US$489.050.0000% mcap0.8% of flowCommon StockSEC:0001567619-22-002287:0
10 shares@ US$666.140.4% of flowCommon StockSEC:0001567619-21-019216:0
2,402 shares@ US$85.0010.8% of flowCommon StockSEC:0001567619-21-015281:0
10 shares@ US$678.530.4% of flowCommon StockSEC:0001567619-21-014356:0
5,250 shares0Common StockSEC:0001209191-21-036384:0
2,500 shares@ US$85.0010.8% of flowCommon StockSEC:0001567619-21-011069:0
11 shares@ US$548.990.3% of flowCommon StockSEC:0001567619-21-009017:0
71 sharesCommon StockSEC:0000899243-16-012557:0
5,416 sharesCommon StockSEC:0001179110-16-016899:0
5,416 sharesCommon StockSEC:0001179110-16-016899:1
25 of 25 declarations
